NDAOPHTHALMICSOLUTION/DROPS1 Generic Approved
Approved
Feb 2012
Lifecycle
Peak
Competitive Pressure
45/100
Data completeness
3/8 — Basic
Drug data last refreshed 5h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
COSOPT PF is a fixed-dose combination ophthalmic solution containing dorzolamide (carbonic anhydrase inhibitor) and timolol (beta-blocker) for topical eye administration. It is indicated for reducing intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The dual mechanism targets aqueous humor production via two distinct pathways to maximize IOP reduction.
$0.893MPart D
PeakProduct is at peak commercial maturity with established claims volume; brand teams focus on maintaining market share against moderate competitive pressure (45/100).
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
COSOPT PF offers stable, mature-stage career exposure in ophthalmology with emphasis on managed care navigation and competitive market positioning. Professionals joining this franchise focus on defending market share and optimizing payer relationships in a well-established therapeutic area rather than driving innovation.
Brand ManagerMedical Science Liaison
Worked on COSOPT PF at Thea Pharma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.